CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
17/06/2026
Voltar para busca
Dado oficial do USPTO
GAIPET
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
18/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
08/11/2023
Data de registro
28/01/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/01/2025
Última transação
18/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
CN
Examinador
MORAN, CAROLINE L
Unidade examinadora
N70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
ARGORNA PHARMACEUTICALS CO., LTD
Representantes
Jonathan M. Rixen Dennemeyer & Associates, LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical reagentsother than for medical or veterinary purposes; biological preparations for use in industry and scienceother than for medical or veterinary purposes; diagnostic preparations for scientific useother than for medical or veterinary purposes; test paperchemical; chemical preparations for scientific purposesother than for medical or veterinary use; biochemicals preparations for scientific use; chemical substances for analyses in laboratories for scientific useother than for medical or veterinary purposes; reagent paperother than for medical or veterinary purpose; biological preparations for cell cultureother than for medical or veterinary use; diagnostic reagents and preparations for scientific use except for medical and veterinary use; active chemical ingredients for use in the manufacture of pharmaceuticals for treating tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia
Classe 5
Medicines for human purposes for treating tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; biochemical medicines for the treatment of tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; pharmaceutical preparations for the treatment of tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; chemical reagents for medical and veterinary purposes; biological preparations for medical purposes for treating tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; reagent paper for medical purposes; drugs for medical purposes for treating tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; diagnostic preparations for medical purposes; vaccines
Classe 42
Scientific development and research services in the field of drugs; vaccine research and development services; scientific research and development of new products for others; scientific research; research of biochemistry; biotechnology research; pharmaceutical drug research; development services in the field of pharmaceutical drugs; medical research service; biomedical research services
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/09/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2025
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
29/08/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/08/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/08/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/08/2025
FIMP
FINAL DISPOSITION PROCESSED
15/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/04/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
28/01/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/12/2024
PUBO
PUBLISHED FOR OPPOSITION
10/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/11/2024
RFNT
REFUSAL PROCESSED BY IB
11/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/07/2024
RFRR
REFUSAL PROCESSED BY MPU
24/07/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/06/2024
CNRT
NON-FINAL ACTION WRITTEN
27/06/2024
DOCK
ASSIGNED TO EXAMINER
17/06/2024
MAFR
APPLICATION FILING RECEIPT MAILED
05/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/03/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GAIPET ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.